Nano‐Armed Limosilactobacillus reuteri for Enhanced Photo‐Immunotherapy and Microbiota Tryptophan Metabolism against Colorectal Cancer
Advanced Science · 2025-02 · 12 (7)
DOI: 10.1002/advs.202410011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.12.2024. Verfasst von Haiting Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Resource Insects, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Chongqing, 400715, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Immunotherapy, Limosilactobacillus reuteri, Tryptophan. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Venture & Innovation Support Program for Chongqing Overseas Returnees.
Abstract (Originalsprache)
Despite being a groundbreaking approach to treating colorectal cancer (CRC), the efficacy of immunotherapy is significantly compromised by the immunosuppressive tumor microenvironment and dysbiotic intestinal microbiota. Here, leveraging the superior carrying capacity and innate immunity‐stimulating property of living bacteria, a nanomedicine‐engineered bacterium, LR‐S‐CD/CpG@LNP, with optical responsiveness, immune‐stimulating activity, and the ability to regulate microbiota metabolome is developed. Immunoadjuvant (CpG) and carbon dot (CD) co‐loaded plant lipid nanoparticles (CD/CpG@LNPs) are constructed and conjugated to the surface of Limosilactobacillus reuteri (LR) via reactive oxygen species (ROS)‐responsive linkers. The inherent photothermal and photodynamic properties of oral CD/CpG@LNPs induce in situ cytotoxic ROS generation and immunogenic cell death of colorectal tumor cells. The generated neoantigens and the released CpG function as a potent in situ vaccine that stimulates the maturation of immature dendritic cells. The mature dendritic cells and metabolites secreted by LR subsequently facilitated the tumor infiltration of cytotoxic T lymphocytes to eradicate colorectal tumors. The further in vivo results demonstrate that the photo‐immunotherapy and intestinal microbial metabolite regulation of LR‐S‐CD/CpG@LNPs collectively suppressed the growth of orthotopic colorectal tumors and their liver metastases, presenting a promising avenue for synergistic treatment of CRC via the oral route.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Resource Insects, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Chongqing, 400715, China.
- Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and…
- Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
- Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713 AV, Netherlands.
- W.J. Kolff Institute for Biomedical Engineering and Materials Science, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713 AV, Netherlands.
- 3Bs Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, A…
ORCID-Profile: Bo Xiao
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Venture & Innovation Support Program for Chongqing Overseas Returnees
- Science and Technology Department of Jiangxi Province
- Science and Technology Research Program of Chongqing Municipal Education Commission
- Sichuan Science and Technology Program
- Chongqing Science and Technology Foundation
Zitieren
APA
Xu, H., Wang, Y., Liu, G., Zhu, Z., Shahbazi, M. A., Reis, R. L., Kundu, S. C., Shi, X., Zu, M., & Xiao, B. (2025). Nano‐Armed Limosilactobacillus reuteri for Enhanced Photo‐Immunotherapy and Microbiota Tryptophan Metabolism against Colorectal Cancer. Advanced Science, 12(7). https://doi.org/10.1002/advs.202410011
Vancouver
Xu H, Wang Y, Liu G, Zhu Z, Shahbazi MA, Reis RL, et al. Nano‐Armed Limosilactobacillus reuteri for Enhanced Photo‐Immunotherapy and Microbiota Tryptophan Metabolism against Colorectal Cancer. Advanced Science. 2025;12(7). doi:10.1002/advs.202410011
BibTeX
@article{Xu2025,
author = {Xu, Haiting and Wang, Yajun and Liu, Ga and Zhu, Zhenhua and Shahbazi, Mohammad-Ali and Reis, Rui L and Kundu, Subhas C and Shi, Xiaoxiao and Zu, Menghang and Xiao, Bo},
title = {Nano‐Armed Limosilactobacillus reuteri for Enhanced Photo‐Immunotherapy and Microbiota Tryptophan Metabolism against Colorectal Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {7},
doi = {10.1002/advs.202410011}
}
EUVIMED